Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3741985016 | Product containing only papaveretum and scopolamine in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3741986015 | Papaveretum and scopolamine only product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3741987012 | Hyoscine and papaveretum only product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3741985016 | Product containing only papaveretum and scopolamine in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3741986015 | Papaveretum and scopolamine only product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3741987012 | Hyoscine and papaveretum only product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
5575761000241117 | produit contenant seulement du papaveretum et de la scopolamine sous forme parentérale | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Switzerland NRC maintained Module |
5575761000241117 | produit contenant seulement du papaveretum et de la scopolamine sous forme parentérale | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Switzerland NRC maintained Module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection | Is a | True | Product containing only papaveretum and scopolamine in parenteral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier (core metadata concept) |
Reference Sets